Clinical dose ranging studies with finasteride, a type 2 5α-reductase inhibitor, in men with male pattern hair loss

J. L. Roberts, V. Fiedler, J. Imperato-McGinley, D. Whiting, E. Olsen, J. Shupack, D. Stough, R. DeVillez, R. Rietschel, R. Savin, W. Bergfeld, J. Swinehart, T. Funicella, M. Hordinsky, N. Lowe, I. Katz, A. Lucky, L. Drake, V. H. Price, D. WeissE. Whitmore, L. Millikan, S. Muller, C. Gencheff, P. Carrington, B. Binkowitz, P. Kotey, W. He, K. Bruno, C. Jacobsen, L. Terranella, G. J. Gormley, K. D. Kaufman

Research output: Contribution to journalArticlepeer-review

87 Scopus citations

Fingerprint

Dive into the research topics of 'Clinical dose ranging studies with finasteride, a type 2 5α-reductase inhibitor, in men with male pattern hair loss'. Together they form a unique fingerprint.

Medicine & Life Sciences